Table 1.

Source of clinical samples

Sample no.Sample IDSourceSexStageFISH/t(9:22)Figures
1Spirit CML 0762PBMCPND1, 2, 5
2CML 339LeukapheresisFCP+2, 4, 5
3CML 340LeukapheresisMCP+*4, 5
4CML 341 (Fresh)LeukapheresisMCP+*1, 2
5CML 378LeukapheresisFCP+1, 2
6CML 381LeukapheresisFCP+1, 2
7CML 385LeukapheresisMCP+*1, 2
8CML 388LeukapheresisFCP+*1, 2
9CML 411 (Fresh)PBFCPND4, 5
10CML 412 (Fresh)LeukapheresisMCPND2, 4, 5
11CML 441LeukapheresisMCP+2
12CML 442PBFCP+4, 5
13CML 450PBMCP+5
14CML 452LeukapheresisMCP+2
15CML 454 (Fresh)LeukapheresisMCPND3
16CML 456LeukapheresisFCPND3
17CML 457 (Fresh)PBMCPND3, 4
18CML 459LeukapheresisMCPND3
19CML 460 (Fresh)LeukapheresisFCPND1, 3, 4
20CML 461 (Fresh)LeukapheresisFCPND3, 5
  • CP, chronic phase; ND, not determined; PB, peripheral blood.

  • * CD34+CD38 CML LSCs were also confirmed to be Ph+ by fluorescence in situ hybridization after sorting.